Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen

NCT01048827 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Busulfan

Sponsor

University of California, San Francisco